These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clearance of iopromide during haemodialysis with high- and low-flux membranes. Matzkies FK; Tombach B; Kisters K; Schuhmann G; Hohage H; Schaefer RM Acta Radiol; 1999 Mar; 40(2):220-3. PubMed ID: 10080739 [TBL] [Abstract][Full Text] [Related]
4. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure]. Zukowska-Szczechowska E; Moczulski D; Grzeszczak W; Gosek K; Augustyn M; Staszewicz P Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856 [TBL] [Abstract][Full Text] [Related]
5. The influence of cuprophan and polysulfone membranes on dialyzer reusability and intradialytic complications. Kadiri S; Kehinde Z; Arije A; Salako BL Afr J Med Med Sci; 2001 Sep; 30(3):191-4. PubMed ID: 14510127 [TBL] [Abstract][Full Text] [Related]
6. Clinical characterization of Dicea a new cellulose membrane for haemodialysis. Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161 [TBL] [Abstract][Full Text] [Related]
7. [Effect of hemodialysis using cuprophan and polysulfone dialyzers on rosette tests, concentration of immunoglobulins and complement components in serum of patients with chronic renal failure]. Starzyk J; Bartelik S; Sarnecka S Wiad Lek; 1994 Jul; 47(13-14):523-6. PubMed ID: 7716940 [TBL] [Abstract][Full Text] [Related]
8. Beta 2-microglobulin kinetics during haemodialysis and haemofiltration. Flöge J; Granolleras C; Bingel M; Deschodt G; Branger B; Oules R; Koch KM; Shaldon S Nephrol Dial Transplant; 1987; 1(4):223-8. PubMed ID: 3110678 [TBL] [Abstract][Full Text] [Related]
9. Clearance of ceftriaxone during haemodialysis using cuprophane, haemophane and polysulfone dialysers. Gabutti L; Taminelli-Beltraminelli L; Marone C Eur J Clin Pharmacol; 1997; 53(2):123-6. PubMed ID: 9403283 [TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo biocompatibility of substituted cellulose and synthetic membranes. Mandolfo S; Tetta C; David S; Gervasio R; Ognibene D; Wratten ML; Tessore E; Imbasciati E Int J Artif Organs; 1997 Nov; 20(11):603-9. PubMed ID: 9464869 [TBL] [Abstract][Full Text] [Related]
11. Synthetically modified cellulose: an alternative to synthetic membranes for use in haemodialysis? Hoenich NA; Woffindin C; Stamp S; Roberts SJ; Turnbull J Biomaterials; 1997 Oct; 18(19):1299-303. PubMed ID: 9307219 [TBL] [Abstract][Full Text] [Related]
12. Comparison of cellulose diacetate and polysulfone membranes in the outcome of acute renal failure. A prospective randomized study. Gastaldello K; Melot C; Kahn RJ; Vanherweghem JL; Vincent JL; Tielemans C Nephrol Dial Transplant; 2000 Feb; 15(2):224-30. PubMed ID: 10648669 [TBL] [Abstract][Full Text] [Related]
13. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis. de Sá HM; Freitas LA; Alves VC; Garção MF; Rosa MA; Marques AA Am J Nephrol; 2001; 21(4):264-73. PubMed ID: 11509797 [TBL] [Abstract][Full Text] [Related]
14. Effects of Plasma Proteins on the Transport and Surface Characteristics of Polysulfone/Polyethersulfone and Asymmetric Cellulose Triacetate High Flux Dialyzers. Kim TR; Hadidi M; Motevalian SP; Sunohara T; Zydney AL Artif Organs; 2018 Nov; 42(11):1070-1077. PubMed ID: 29774568 [TBL] [Abstract][Full Text] [Related]
15. [Antioxidants and malondialdehyde during hemodialysis with cellulose diacetate and polysulfone membranes]. Eiselt J; Racek J; Holecek V; Krejcová I; Opatrný K Cas Lek Cesk; 1996 Nov; 135(21):691-4. PubMed ID: 8998818 [TBL] [Abstract][Full Text] [Related]
16. [Effect of hemodialysis with cuprophane and polysulfone membranes on counts of leukocytes, granulocytes, monocytes, lymphocytes and lymphocyte subsets]. Moczulski D; Zukowska-Szczechowska E; Grzeszczak W; Religa Z; Cichoń R; Szydłowska I Pol Arch Med Wewn; 1994 Nov; 92(5):400-7. PubMed ID: 7885988 [TBL] [Abstract][Full Text] [Related]
17. Iodixanol is readily eliminated by hemodialysis. Berg KJ; Rolfsen B; Stake G Acta Radiol; 1998 Jul; 39(4):372-4. PubMed ID: 9685821 [TBL] [Abstract][Full Text] [Related]
18. Elimination of the nonionic contrast medium iopromide in end-stage renal failure by hemodialysis. Kierdorf H; Kindler J; Winterscheid R; Hollmann HJ; Vorwerk D; Speck U Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():119-23. PubMed ID: 2568779 [TBL] [Abstract][Full Text] [Related]
19. Effect of permeability on indices of haemodialysis membrane biocompatibility. Masaki T; Gilson J; Leypoldt JK; Cheung AK Nephrol Dial Transplant; 1999 May; 14(5):1176-81. PubMed ID: 10344358 [TBL] [Abstract][Full Text] [Related]
20. Ofloxacin clearance during hemodialysis: a comparison of polysulfone and cellulose acetate hemodialyzers. Thalhammer F; Kletzmayr J; El Menyawi I; Kovarik J; Rosenkranz AR; Traunmüller F; Hörl WH; Burgmann H Am J Kidney Dis; 1998 Oct; 32(4):642-5. PubMed ID: 9774127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]